Exosome RNA Exosome RNA Research & Industry News
Breast cancer is one of the most common cancers worldwide, and detecting it early is crucial for better treatment planning and improving patient outcomes. Researchers at the Beijing Institute of Technology have developed an innovative method for identifying specific subtypes of exosomes (small particles released by cells) that are associated with breast cancer. Exosomes can play a key role in how cancer cells interact with each other and with the immune system, so being able to pinpoint them precisely could lead to better diagnostics.
The new approach uses a clever dual-marker strategy that combines two nucleic acid aptamers—small molecules that can specifically bind to certain targets—each designed to target different proteins found on the surface of cancer-derived exosomes. These proteins are known as PD-L1 (a molecule involved in immune response regulation) and EpCAM (a protein found on epithelial cells). The aptamers are labeled with fluorescent dyes, which allows scientists to track and detect the exosomes through a special technique known as Förster Resonance Energy Transfer (FRET).
When both aptamers bind to their respective targets on the exosomes, the FRET phenomenon occurs, enabling the precise detection of these cancer-related particles. This new method could be applied to fluorescence imaging, allowing researchers to visualize how exosomes interact with immune cells. Not only does this help understand the biology of breast cancer, but it also opens the door for developing a non-invasive diagnostic tool that could improve early detection and treatment of the disease.
